Abstract
Pseudomonas aeruginosa (Pae) is notorious for its high-level resistance toward clinically used antibiotics. In fact, Pae has rendered most antimicrobials ineffective, leaving polymyxins and aminoglycosides as last-resort antibiotics. Although several resistance mechanisms of Pae are known toward these drugs, a profounder knowledge of hitherto unidentified factors and pathways appears crucial to develop novel strategies to increase their efficacy. Here, we have performed for the first time transcriptome analyses and ribosome profiling in parallel with strain PA14 grown in synthetic cystic fibrosis medium upon exposure to polymyxin E (colistin) and tobramycin. This approach did not only confirm known mechanisms involved in colistin and tobramycin susceptibility but revealed also as yet unknown functions/pathways. Colistin treatment resulted primarily in an anti-oxidative stress response and in the de-regulation of the MexT and AlgU regulons, whereas exposure to tobramycin led predominantly to a rewiring of the expression of multiple amino acid catabolic genes, lower tricarboxylic acid (TCA) cycle genes, type II and VI secretion system genes and genes involved in bacterial motility and attachment, which could potentially lead to a decrease in drug uptake. Moreover, we report that the adverse effects of tobramycin on translation are countered with enhanced expression of genes involved in stalled ribosome rescue, tRNA methylation and type II toxin-antitoxin (TA) systems.
Introduction
Pseudomonas aeruginosa (Pae) is a formidable opportunistic pathogen, serving as a primary cause of hospital-acquired infections and a life-threatening complication for patients with cystic fibrosis (CF). Its innate and acquired resistance to most antibiotics often forces clinicians to rely on "last-resort" treatments: polymyxins (such as colistin) and aminoglycosides (such as tobramycin).
While specific resistance mutations are well-documented, a holistic understanding of the bacterial cell's global response to these stressors in clinically relevant environments has been lacking. Most prior studies focused solely on the transcriptome (mRNA levels). However, mRNA levels do not always correlate with actual protein production. This study addresses this gap by mapping the transcriptome and the translatome (actual protein synthesis) in parallel, providing a high-resolution view of the bacterial survival strategy.
Methods and Datasets
To capture a more accurate picture of bacterial physiology, the researchers utilized two complementary sequencing techniques:
- RNA-seq: To measure the total pool of mRNA transcripts.
- Ribo-seq (Ribosome Profiling): To capture "ribosomal footprints," identifying the specific mRNA segments currently being translated into proteins.
Experiments were conducted using the highly virulent clinical strain PA14 (Reference Genome: NC_008463.1). Crucially, the bacteria were grown in Synthetic Cystic Fibrosis Medium (SCFM), which mimics the chemical environment of a CF patient's lung, rather than standard laboratory media. The raw sequencing data is available via the European Nucleotide Archive (ENA) under accessions PRJEB41029 (RNA-seq) and PRJEB41027 (Ribo-seq).
Key Results
Transcript-Protein Mismatch and Global Correlation
A major finding was that the majority of genes were regulated exclusively at either the transcriptional or translational level, underscoring the necessity of parallel profiling. Interestingly, the study observed that the Spearman correlation between the transcriptome and translatome increased significantly under antibiotic stress.
As shown in Figure 1, the correlation coefficient rose from $\rho=0.68$ in control conditions to $\rho=0.91$ under tobramycin exposure. This suggests that under extreme stress, the bacterial cell tightens the link between what it "orders" (mRNA) and what it "builds" (protein) to ensure a rapid and efficient response.
Colistin: Oxidative Stress and Iron Homeostasis
Beyond its known role in disrupting bacterial membranes, colistin was found to trigger a massive anti-oxidative stress response. The bacteria up-regulated the MexT and AlgU regulons to manage envelope stress and reactive oxygen species (ROS). Furthermore, colistin caused a dramatic drop in iron acquisition genes; for instance, the heme acquisition protein hasAp showed a staggering 1282-fold decrease in mRNA levels.
Tobramycin: Metabolic Rewiring and Ribosome Rescue
Tobramycin exposure induced a state of metabolic "hunkering down." The bacteria down-regulated the TCA cycle and amino acid catabolism, likely reducing the proton motive force and thereby decreasing the active uptake of the drug. Additionally, the bacteria "closed their gates" by down-regulating genes for motility (flagella/pili) and Type II/VI secretion systems, potentially reducing permeability.
To counter the primary effect of tobramycin—ribosome stalling and the production of defective proteins—Pae ramped up trans-translation mechanisms (utilizing tmRNA ssrA and smpB) to rescue stalled ribosomes and clear out "junk" proteins.
Discussion and Future Directions
This study provides the first parallel map of the Pae transcriptome and translatome under antibiotic stress in a CF-like environment. The discovery that ribosome rescue and specific metabolic pathways are essential for surviving tobramycin suggests these could be potent targets for adjuvant therapies. Inhibiting these survival pathways might "re-sensitize" resistant strains to existing drugs.
However, limitations remain. While SCFM is a significant improvement over standard media, it lacks the host immune system and the complex spatial structure of real-world biofilms. Additionally, the study identified numerous "hypothetical proteins" that were highly regulated but remain uncharacterized. These represent a "dark matter" of antibiotic resistance that warrants further biochemical investigation.
Summary updated